Buchumschlag

Los archivos del mal: ¿un discurso sin autor? Ildefonso Nalda Nájera en el Archiv der KZ-Gedenkstätte Mauthausen

Fuente: Redalyc

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Alfonso Rubio Hernández
Format:	Artículo científico
Sprache:	es
Veröffentlicht:	Universidad de Buenos Aires 2019
Schlagworte:	Ciencias de la Información Archiv der KZ Archivos del mal Ildefonso Nalda Nájera Gedenkstätte Mauthausen Centros de Memoria Histórica
Online-Zugang:	Acceder al recurso 1 Acceder al recurso 2 Acceder al recurso 3 Acceder al recurso 4 Acceder al recurso 5 Acceder al recurso 6
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

El mal de archivo en la escritura de la historia
von: RICARDO NAVA MURCIA
Veröffentlicht: (2012)

Vientos de cambio en la tercera enseñanza. El caso del Colegio de San Ildefonso de México, 1834-1852
von: Mónica Hidalgo Pego
Veröffentlicht: (2015)

La conquista de la Sierra : españoles e indígenas de Oaxaca en la época de la Colonia / John K. Chance
von: Chance, John K

La Ley de Represión de la Masonería y el Comunismo (1 de marzo de 1940). Un estudio de algunos aspectos histórico-jurídicos
von: Juan José Morales Ruiz
Veröffentlicht: (2020)

Domar as águas e os sertões da fronteira intra-americana: a centralidade dos caminhos fluviais nas disputas luso-espanholas do Tratado de Santo Ildefonso
von: Adilson Junior Ishihara Brito
Veröffentlicht: (2019)

AI‐Based Prediction of PROTAC‐ and Molecular Glue‐Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz‐2
von: Lino Riepenhausen, et al.
Veröffentlicht: (2026)

Piperlongumine and its derivatives against cancer: A recent update and future prospective
von: Shasank S. Swain, et al.
Veröffentlicht: (2024)

Ultra‐Fast UPLC‐MS/MS Method for the Ripretinib Quantification in the HLMs Matrix With Metabolic Stability Assessment: In‐Silico Study for Toxic Alerts and the Metabolic Lability
von: Mohamed W. Attwa, et al.
Veröffentlicht: (2025)

Issue Information: Arch Pharm (1/2026)
Veröffentlicht: (2026)

Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics
von: Enrico Mario Alessandro Fassi, et al.
Veröffentlicht: (2025)

Novel Purine‐Based Natural Products as Inhibitors of Cholinesterases and Monoamine Oxidases Presenting Potential Multitarget Therapeutics Tackling Alzheimer's Disease
von: Amira E. Shaaban, et al.
Veröffentlicht: (2025)

Development of Potent Type V MAPK Inhibitors: Design, Synthesis, and Biological Evaluation of Benzothiazole Derivatives Targeting p38α MAPK in Breast Cancer Cells
von: Bayan Zoatier, et al.
Veröffentlicht: (2025)

Design, Synthesis, and Biological Evaluation of Novel Benzimidazole/Schiff Base Hybrid Derivatives With Potential Biological Activities
von: Mohamed Y. Abdel‐Hady, et al.
Veröffentlicht: (2025)

Quinolinone Derivatives Suppress Angiogenesis in Human Umbilical Vein Endothelial Cells by Blocking the VEGF‐Induced VEGFR2 Signaling Pathway
von: Xiaoxi Lin, et al.
Veröffentlicht: (2025)

Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases
von: Johannes Seitz, et al.
Veröffentlicht: (2024)

Design, synthesis, and biological evaluation of naphthalene imidazo[1,2‐b]pyridazine hybrid derivatives as VEGFR selective inhibitors
von: Shuang Wang, et al.
Veröffentlicht: (2024)

Morpholinodiazenyl chalcone blocks influenza A virus capsid uncoating by perturbing the clathrin‐mediated vesicular trafficking pathway
von: Ahammed A. Thottasseri, et al.
Veröffentlicht: (2024)

Exosomal miR‐122, miR‐128, miR‐200, miR‐298, and miR‐342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR‐4/FoxO3 pathway
von: Ahmed M. Samy, et al.
Veröffentlicht: (2024)

Current Landscape of Indole Hybrids in the Design and Development of Anti‐Alzheimer Agents: Structural Insights, Therapeutic Potential and In Silico Studies
von: Akshad D. Bagul, et al.
Veröffentlicht: (2026)

Harnessing PHGDH Inhibition for Cancer Therapy: Mechanisms, SAR, Computational Aspects, and Clinical Potential
von: Md Mustahidul Islam, et al.
Veröffentlicht: (2025)

Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”
Veröffentlicht: (2025)

Exploring Novel Nitrofuryl‐1,3,4‐Thiadiazole‐Based Derivatives: Design, Synthesis, and Evaluation of In Vitro Leishmanicidal and Trypanocidal Activity
von: Alireza Mousavi, et al.
Veröffentlicht: (2026)

Multi‐Angle Bioactivity Cartography for Computational Screening and Mechanistic Analysis of AChE Inhibitors From Yellow Gastrodia elata
von: Ruijun Sun, et al.
Veröffentlicht: (2025)

Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation
von: Wenxiu Sun, et al.
Veröffentlicht: (2024)

Inhibition of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1): A Medicinal Chemistry Approach at the Crossroad of Immunotherapy and Metabolic Modulation
von: Abdur Rauf, et al.
Veröffentlicht: (2026)

Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate
von: Giada Cernicchi, et al.
Veröffentlicht: (2024)

Chicoric acid alleviates rotenone‐induced motor dysfunction in mice: Targeting PI3K/AKT/caspase‐3‐associated apoptosis and neuroinflammation
von: Mohamed I. Fahmy, et al.
Veröffentlicht: (2025)

A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine‐incorporating molecules
von: Hamada S. Abulkhair, et al.
Veröffentlicht: (2025)

Novel N‐pyrocatechoyl and N‐pyrogalloyl hydrazone antioxidants endowed with cytotoxic and antibacterial activity
von: Jovica Branković, et al.
Veröffentlicht: (2024)

Structure‐Based Design of Chiral Thioureas as Anticholinesterase Inhibitors Using Enantiopure α‐Methylbenzylamines: Synthesis, Enzyme Inhibition, and In Silico Studies
von: Zafer Bulut, et al.
Veröffentlicht: (2025)

Design and synthesis of novel substituted s‐triazines tethered benzenesulfonamides as potential antimicrobial candidates: Antibiofilm and bacterial protein permeability assessments
von: Ahmed A. Al‐Karmalawy, et al.
Veröffentlicht: (2025)

Green Synthetic Strategies for Pyrazole Derivatives: A Comprehensive Review
von: Radhika Kachhadiya, et al.
Veröffentlicht: (2025)

Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents
von: Demokrat Nuha, et al.
Veröffentlicht: (2024)

Spirooxadiazoline‐oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells
von: Liviane D. de Azevedo, et al.
Veröffentlicht: (2024)

Unveiling the Therapeutic Potential of Dulaglutide in Mitigating Tacrolimus‐Induced Nephrotoxicity Through Targeting the miR‐22/HMGB‐1/TLR4/MyD88/NF‐κB Trajectory
von: Rasha Abdelhady, et al.
Veröffentlicht: (2025)

Novel tetrahydropyran‐triazole hybrids with antiproliferative activity against human tumor cells
von: Vanesa Quintana, et al.
Veröffentlicht: (2024)

Indoles—A Targeting the PI3K/Akt/mTOR Pathway: Recent Advances in Strategic Design, Mechanism, and Future Perspectives
von: Harish Chandra Vishwakarma, et al.
Veröffentlicht: (2026)

Development and Synthesis of Bioactive (3‐Arylediene‐1‐phenyl‐1 H ‐pyrazol‐4‐yl)acryloyl‐4‐hydroxy‐6‐methyl‐2 H ‐pyran‐2‐ones With Anti‐Malarial and Anti‐Inflammatory Activities
von: Priyanka Rani, et al.
Veröffentlicht: (2026)

Novel RP‐HPLC method for estimation of a newly developed combination of tizanidine and etoricoxib in rat plasma: Eight criteria for greens evaluation
von: Eman A. Assirey, et al.
Veröffentlicht: (2024)

Synthesis and evaluation of febrifugine derivatives as anticoccidial agents
von: Da Tang, et al.
Veröffentlicht: (2024)